Daratumumab-based first-line therapy benefit multiple myeloma patients in a real-world setting: a multi-center retrospective propensity score-match study. [PDF]
Wang Y +26 more
europepmc +1 more source
Patient With MGRS/PGNMID Without Detection of a Peripheral Clone: Case Report and Literature Review. [PDF]
Larrazábal A +2 more
europepmc +1 more source
Brazilian consensus recommendations on the diagnosis and treatment of light chain amyloidosis. [PDF]
Garibaldi PMM +8 more
europepmc +1 more source
Impact of 1q vulnerabilities in patients treated with anti-CD38 monoclonal antibodies. [PDF]
Sánchez-Tabernero M +10 more
europepmc +1 more source
Exercise-mobilized lymphocytes enhance antibody-based immunotherapy in multiple myeloma through CD16<sup>+</sup> NK cell-mediated cytotoxicity. [PDF]
Chou L +5 more
europepmc +1 more source
Case Report: Dual impact of daratumumab in early T-cell precursor acute lymphoblastic leukemia -- consolidation therapy achieves remission and eliminates donor-specific HLA antibodies. [PDF]
Wong KL, Tuy T, Quek J, Linn YC.
europepmc +1 more source
Daratumumab in the Treatment of Multiple Myeloma: Real World Evidence (2018-2024) at the a. Gemelli Polyclinic (Rome) and Comparison With Registration Studies. [PDF]
Favia M +9 more
europepmc +1 more source
Acute kidney injury with interstitial hemorrhage in renal heavy chain amyloidosis: a clinicopathologic case report. [PDF]
Mori N +12 more
europepmc +1 more source

